0.5455
Moleculin Biotech Inc Azioni (MBRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
|
3.75%
5.72
|
5.943 | 6.643 | 7.135 | 6.185 |
Operating Income/Loss |
3.75%
-5.72
|
-5.943 | -6.643 | -7.135 | -6.185 |
Income/Loss From Continuing Operations Before Tax |
18.71%
-7.64
|
-6.436 | -1.882 | -10.59 | -4.319 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
18.71%
-7.64
|
-6.436 | -1.882 | -10.59 | -4.319 |
|
18.71%
-7.64
|
-6.436 | -1.882 | -10.59 | -4.319 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
66.17%
15.53
|
9.3438 | 0.5322 | 3.7143 | 2.5432 |
Basic Earnings Per Share |
28.99%
-0.49
|
-0.69 | 0.51 | -2.85 | -1.70 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):